Firefly Neuroscience, Inc. (AIFF)Technology | Software - Application | Kenmore, United States | NasdaqCM
1.15 USD
After hours: 1.15 +0.00 (0.026%) ⇧ (July 13, 2026, 6:03 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:55 a.m. EDT
The immediate outlook is neutral despite a recent surge driven by news of FDA clearance and acquisition talks; the stock is currently trading below its 50-day moving average, suggesting the rally may be pausing rather than continuing immediately. However, the long-term picture is severely compromised by a brutal multi-year decline where the price has lost nearly 30% cumulatively over nine years, with four consecutive years of negative annual returns ending recently. This persistent downward trajectory indicates a structural deterioration in market valuation that outweighs the positive catalysts. Furthermore, the company is burning significant cash with negative operating and free cash flows, while returning nothing to shareholders via dividends. The business faces a precarious path where recent operational wins have not yet translated into a sustainable recovery in share price or profitability. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.159799 |
| AutoETS | 0.164758 |
| MSTL | 0.166158 |
| MSTL_126 | 0.168553 |
| AutoTheta | 0.172168 |
| MSTL_70 | 0.220769 |
| MSTL_70_126 | 0.221078 |
Forecast horizon: 60 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.72 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.365 |
| Excess Kurtosis | -0.86 |
| Attribute | Value |
|---|---|
| Sector | Technology |
| Revenue per Share | 0.113 |
| Market Cap | 17,946,694 |
| Website | https://fireflyneuro.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5950704 |
| Address1 | 1,100 Military Road |
| All Time High | 990.0 |
| All Time Low | 0.62 |
| Ask | 1.47 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 115,630 |
| Average Daily Volume3 Month | 450,373 |
| Average Volume | 450,373 |
| Average Volume10Days | 115,630 |
| Bid | 0.8208 |
| Bid Size | 2 |
| Book Value | 0.568 |
| City | Kenmore |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.15 |
| Current Ratio | 1.818 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.2176 |
| Day Low | 1.14 |
| Display Name | Firefly Neuroscience |
| Ebitda | -8,383,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.763 |
| Enterprise To Revenue | 9.331 |
| Enterprise Value | 14,780,547 |
| Eps Trailing Twelve Months | -0.36 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.6102 |
| Fifty Day Average Change | -0.46020007 |
| Fifty Day Average Change Percent | -0.28580305 |
| Fifty Two Week Change Percent | -59.507042 |
| Fifty Two Week High | 3.63 |
| Fifty Two Week High Change | -2.48 |
| Fifty Two Week High Change Percent | -0.6831956 |
| Fifty Two Week Low | 0.62 |
| Fifty Two Week Low Change | 0.53 |
| Fifty Two Week Low Change Percent | 0.85483867 |
| Fifty Two Week Range | 0.62 - 3.63 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 765,639,000,000 |
| Float Shares | 13,678,563 |
| Free Cashflow | -9,618,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 17 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.51957 |
| Gross Profits | 823,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.28276 |
| Held Percent Institutions | 0.07865 |
| Implied Shares Outstanding | 15,605,821 |
| Industry | Software - Application |
| Industry Disp | Software - Application |
| Industry Key | software-application |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,723,507,200 |
| Last Split Factor | 1:3 |
| Long Business Summary | Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York. |
| Long Name | Firefly Neuroscience, Inc. |
| Market | us_market |
| Market Cap | 17,946,694 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1832386409 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -9,285,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 17,946,694 |
| Open | 1.15 |
| Operating Cashflow | -7,631,000 |
| Operating Margins | -4.14433 |
| Payout Ratio | 0.0 |
| Phone | 888 237 6412 |
| Post Market Change | 0.00030004978 |
| Post Market Change Percent | 0.026091285 |
| Post Market Price | 1.1503 |
| Post Market Time | 1,783,980,223 |
| Previous Close | 1.15 |
| Price Hint | 4 |
| Price To Book | 2.0246477 |
| Price To Sales Trailing12 Months | 11.329984 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.353 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 1.2176 |
| Regular Market Day Low | 1.14 |
| Regular Market Day Range | 1.14 - 1.2176 |
| Regular Market Open | 1.15 |
| Regular Market Previous Close | 1.15 |
| Regular Market Price | 1.15 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 56,863 |
| Return On Assets | -0.45654 |
| Return On Equity | -1.31445 |
| Revenue Growth | 10.279 |
| Revenue Per Share | 0.113 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Technology |
| Sector Disp | Technology |
| Sector Key | technology |
| Shares Outstanding | 15,605,821 |
| Shares Percent Shares Out | 0.045 |
| Shares Short | 702,489 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 738,854 |
| Short Name | Firefly Neuroscience, Inc. |
| Short Percent Of Float | 0.0525 |
| Short Ratio | 2.0 |
| Source Interval | 15 |
| State | NY |
| Symbol | AIFF |
| Total Cash | 3,127,000 |
| Total Cash Per Share | 0.201 |
| Total Debt | 0 |
| Total Revenue | 1,584,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.36 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.64705 |
| Two Hundred Day Average Change | -0.49705005 |
| Two Hundred Day Average Change Percent | -0.301782 |
| Type Disp | Equity |
| Volume | 56,863 |
| Website | https://fireflyneuro.com |
| Zip | 14,217 |